XML 43 R32.htm IDEA: XBRL DOCUMENT v3.22.4
Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2022
USD ($)
segment
Dec. 31, 2021
USD ($)
Accounting Policies [Abstract]    
Number of operating segments | segment 1  
Accrued Clinical Trial Expenses $ 2,300  
Research and development expense $ 27,100  
Payment terms Payment terms and conditions vary by contracts, although terms generally include a requirement of payment within 30 to 45 days after invoice.  
Error Corrections and Prior Period Adjustments Restatement [Line Items]    
Accumulated deficit $ (298,100) $ (259,810)
Accrued liabilities 5,177 $ 4,527
Correction of Series A Convertible Preferred Stock Cumulative Dividend Liability    
Error Corrections and Prior Period Adjustments Restatement [Line Items]    
Accumulated deficit 400  
Accrued liabilities $ 400